Arthur Goldstuck chooses his three stand-out serious gadgets of the year.
The rainbow nation and our national brand's credibility is in trouble, says Solly Moeng.
At France's Rungis market, a tray of fat white truffles can sell for €1 800 a kilo.
India's Supreme Court has rejected German drugmaker Bayer's plea to block production of a cheaper generic version of a patented cancer drug.
Global vaccines alliance Gavi says it is committing up to $300m to buy Ebola vaccines while waiting for WHO's nod for procurement.
The Competition Commission has approved the merger of the Alpha Pharm group of regional pharmaceutical distributors into a single national company.
GlaxoSmithKline has decided not to sell a portfolio of older drugs marketed in North America and Europe after considering offers from potential buyers.
Private hospital group Mediclinic International will list on the Namibian Stock Exchange.
Ascendis Health has successfully concluded two separate BBBEE deals to the combined value of R140m.
The Western world's first gene therapy drug is set to go on sale in Germany with a €1.1m price tag, a new record for a medicine to treat a rare disease.
The demand for private health care in SA is expected to remain strong, which will support Netcare's growth over the next few years, says group CEO Richard Friedland.
Executives from AstraZeneca will present further details of its new drugs to investors at a six-hour meeting.
AstraZeneca, determined to show it has a strong independent future after seeing off a
$118bn bid, says it has made good progress in developing new drugs.
Bird flu was found on a duck farm in England days after it was discovered in Dutch chickens, forcing authorities to destroy poultry and restrict exports.
Get smart on investment and end the year with peace of mind, says Mike Abbott.
From boot sales to global stage for Khayelitsha entrepreneur.
I will be working in Saudi Arabia on a one-year contract - how will I be taxed?
Jozi ratepayers say Capetonians frustrated by rate clearance delays are not alone.
Real estate has emerged from one of its toughest down-cycles, says an expert.
An irate Cell C client is making a fresh bid to remove his blacklisting.
Compound interest can work for or against you, says an expert.
Discovery sheds light on the debate about members' claims from the Road Accident Fund.
The company at the centre of a probe into why more than a dozen women have died after being sterilised in India has denied responsibility.
Pfizer appears unlikely to make a fresh bid for AstraZeneca in 12 days time, when an enforced cooling-off period ends, sources say.
News channel ANN7 has tripped over itself by posting content on social media that appears to confuse the revenue service with the Reserve Bank.
Unwise as they may get priced out of the market.
I don't employ a domestic worker.
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Your opinion on you, me and everyone.
Get us in your home, on your television.
Lost? Confused? Problems? Let us help you.